Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vitamins01:30

Vitamins

Vitamins, derived from the Latin word for life, are essential organic substances required in small quantities for optimal growth and overall well-being. Unlike other organic nutrients, vitamins don't act as sources of energy or building materials but rather facilitate these nutrients' utilization by the body. Vitamins are predominantly coenzymes, assisting enzymes in specific chemical actions, like the oxidation of glucose for energy involving B vitamins. Most vitamins are not produced in our...
Sedatives and Hypnotics Drugs: Benzodiazepines01:19

Sedatives and Hypnotics Drugs: Benzodiazepines

Benzodiazepines have both sedative and hypnotic properties. They include compounds such as diazepam (Valium) and alprazolam (Xanax). Structurally, their cores are similar, consisting of the fusion of a benzene ring and a diazepine ring, but they share a common mechanism of action in the central nervous system (CNS).
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
CNS Depressants: Barbiturates and Benzodiazepines01:14

CNS Depressants: Barbiturates and Benzodiazepines

CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
Electrophilic Aromatic Substitution: Nitration of Benzene01:20

Electrophilic Aromatic Substitution: Nitration of Benzene

The nitration of benzene is an example of an electrophilic aromatic substitution reaction. It involves the formation of a very powerful electrophile, the nitronium ion, which is linear in shape. The reaction occurs through the interaction of two strong acids, sulfuric and nitric acid.
Anxiolytic Drugs: Benzodiazepines and Buspirone01:29

Anxiolytic Drugs: Benzodiazepines and Buspirone

Benzodiazepines are a class of anxiolytic drugs known for their rapid efficacy and high therapeutic-to-lethal dose ratio, but with a potential risk of drug dependence. These drugs are lipophilic, allowing for rapid absorption after oral administration, eventually reaching the central nervous system (CNS). Once in the CNS, benzodiazepines bind to the allosteric site of the GABAA receptor. This binding enhances the inhibitory effects of the neurotransmitter GABA. By doing so, they prevent...
CNS Depressants: Alcohol and Nicotine01:27

CNS Depressants: Alcohol and Nicotine

Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

ASCEND: a randomised, double-blinded, placebo-controlled, phase II study of gemcitabine and nab-paclitaxel with LSTA1 in untreated metastatic pancreatic adenocarcinoma. An Australasian Gastro-Intestinal Trials Group (AGITG) trial.

ESMO gastrointestinal oncology·2026
Same author

Hypo-Fractionated Radiotherapy to the Cavity for Resected Brain Metastases: A UK Series.

Clinical oncology (Royal College of Radiologists (Great Britain))·2025
Same author

Molecular typing of <i>Leptospira</i> spp. in farmed and wild mammals reveals new host-serovar associations in New Zealand.

New Zealand veterinary journal·2023
Same author

Characterization of buried interfaces using Ga Kα hard X-ray photoelectron spectroscopy (HAXPES).

Faraday discussions·2022
Same author

Loco-regional recurrence after skin and nipple-sparing mastectomy and immediate breast reconstruction using free flap autologous tissue in a single institution.

Journal of plastic, reconstructive & aesthetic surgery : JPRAS·2021
Same author

The feasibility of a randomised control trial to assess physiotherapy against surgery for recurrent patellar instability.

Pilot and feasibility studies·2020

Related Experiment Video

Updated: Jul 3, 2026

Recording Brain Electromagnetic Activity During the Administration of the Gaseous Anesthetic Agents Xenon and Nitrous Oxide in Healthy Volunteers
14:52

Recording Brain Electromagnetic Activity During the Administration of the Gaseous Anesthetic Agents Xenon and Nitrous Oxide in Healthy Volunteers

Published on: January 13, 2018

Nitrous oxide-induced vitamin B(12) deficiency.

M Jameson1, S Roberts, N E Anderson

  • 1Departments of Clinical Oncology, Auckland Hospital, Auckland, New Zealand.

Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia
|July 22, 2008
PubMed
Summary

Nitrous oxide exposure can trigger peripheral neuropathy in patients with vitamin B12 deficiency. Cyclophosphamide treatment may exacerbate these neurological symptoms by reducing available vitamin B12 stores.

More Related Videos

A Novel Inhalation Mask System to Deliver High Concentrations of Nitric Oxide Gas in Spontaneously Breathing Subjects
05:46

A Novel Inhalation Mask System to Deliver High Concentrations of Nitric Oxide Gas in Spontaneously Breathing Subjects

Published on: May 4, 2021

Chemiluminescence-based Assays for Detection of Nitric Oxide and its Derivatives from Autoxidation and Nitrosated Compounds
08:23

Chemiluminescence-based Assays for Detection of Nitric Oxide and its Derivatives from Autoxidation and Nitrosated Compounds

Published on: February 16, 2022

Related Experiment Videos

Last Updated: Jul 3, 2026

Recording Brain Electromagnetic Activity During the Administration of the Gaseous Anesthetic Agents Xenon and Nitrous Oxide in Healthy Volunteers
14:52

Recording Brain Electromagnetic Activity During the Administration of the Gaseous Anesthetic Agents Xenon and Nitrous Oxide in Healthy Volunteers

Published on: January 13, 2018

A Novel Inhalation Mask System to Deliver High Concentrations of Nitric Oxide Gas in Spontaneously Breathing Subjects
05:46

A Novel Inhalation Mask System to Deliver High Concentrations of Nitric Oxide Gas in Spontaneously Breathing Subjects

Published on: May 4, 2021

Chemiluminescence-based Assays for Detection of Nitric Oxide and its Derivatives from Autoxidation and Nitrosated Compounds
08:23

Chemiluminescence-based Assays for Detection of Nitric Oxide and its Derivatives from Autoxidation and Nitrosated Compounds

Published on: February 16, 2022

Area of Science:

  • Neurology
  • Hematology
  • Anesthesiology

Background:

  • Vitamin B12 deficiency can lead to peripheral neuropathy.
  • Nitrous oxide is known to inactivate vitamin B12.
  • Cyclophosphamide is a chemotherapy agent with potential hematologic side effects.

Purpose of the Study:

  • To report two cases of peripheral neuropathy in patients with asymptomatic vitamin B12 deficiency.
  • To investigate the potential role of nitrous oxide exposure and cyclophosphamide treatment in triggering neurological symptoms.
  • To highlight the temporal relationship between these exposures and symptom onset.

Main Methods:

  • Case report of two patients.
  • Clinical observation of neurological symptoms development.
  • Biochemical analysis of serum vitamin B12 levels.
  • Assessment of symptom resolution following vitamin B12 replacement therapy.

Main Results:

  • Both patients presented with peripheral neuropathy 6-7 weeks after nitrous oxide exposure and shortly after cyclophosphamide treatment.
  • Serum vitamin B12 levels were critically low (<20 pmol/l).
  • Neurological symptoms resolved completely after vitamin B12 supplementation.

Conclusions:

  • Nitrous oxide exposure is a likely trigger for peripheral neuropathy in individuals with underlying vitamin B12 deficiency.
  • Cyclophosphamide treatment may have contributed to the onset or severity of symptoms by further depleting vitamin B12.
  • This case series suggests a potential interaction between nitrous oxide, cyclophosphamide, and vitamin B12 metabolism.